Results 251 to 260 of about 28,226,052 (304)

Calcineurin Inhibitor–Free, mTOR‐Based Immunosuppression in Chimeric Antigen Receptor T‐Cell Therapy for Post‐Transplant Lymphoproliferative Disorder

open access: yeseJHaem, Volume 7, Issue 6, December 2026.
ABSTRACT Introduction Relapsed/refractory post‐transplant lymphoproliferative disorder (PTLD) remains a challenging complication after solid organ transplantation (SOT), requiring complex balancing of immune‐suppressive therapy (IST) and lymphoma‐directed therapies. Methods We report the case of a 40‐year‐old female kidney‐pancreas transplant recipient
Maria Mappoura   +21 more
wiley   +1 more source

The MHC-I related protein 1 MR1 can bind host purine catabolites. [PDF]

open access: yesJ Biol Chem
Abdelaal MR   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy